pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4254 |
Genomic Coordinates | chr1: 31758660 - 31758735 |
Description | Homo sapiens miR-4254 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4254 | ||||||||||||||||||
Sequence | 44| GCCUGGAGCUACUCCACCAUCUC |66 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PSMD11 | ||||||||||||||||||||
Synonyms | Rpn6, S9, p44.5 | ||||||||||||||||||||
Description | proteasome 26S subunit, non-ATPase 11 | ||||||||||||||||||||
Transcript | NM_002815 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PSMD11 | |||||||||||||||||||||
3'UTR of PSMD11 (miRNA target sites are highlighted) |
>PSMD11|NM_002815|3'UTR 1 AGTTGGATCTGTAGCGGTCCTTTGGAGAGTGTGTGTGGCGGGAGAGTGAAACCTTGGGGGAAAATGCTAGGAGATTCTTT 81 TTTCTTTTTGTTCTACTTTTCGCTCGGAAAGTTTTTAAATCCTCATTTGGTGCATCTGTATTCCAGCCAATAGGTGTGCC 161 AGTTTTCATGTAATCTTTACTGGCCCAACTTGGGAGTGGGGAAATTGCTTAAAAAAAAAGAAAAAGAAAAAAAAAAAGAT 241 TATTCTAAATAAAAGGAAAAAGGCTTACACTACCTAAAGCTGTGCTCTCTGCCTCCTGGGAGAGGGCCGCAAAGCCAGGC 321 ACCCCGCCAACCACTGGGGGTCCTAATCCACCTGCTGGGCATCACCTCTCCTCCTCCTCAGAATTGGGTGTTTGCTGACC 401 ATCAAAAGCAATGACTTTTTATTCTGTTTGTACTGAACCAAAACAAACAACTGTGTATAGACTGCTGTTTTCTTTTTTAT 481 TTGAAATGAGGCATTTTGGTGTTCTTTCCCCTACCATACGGCCTGTCTGCCCTTCCCTCCCCACATTGGCTCCAGCAGAG 561 TAGCCGAAGGTCCTGCCGCCGCCGCCACCACCACCACCACTGCAGCAACAACAGCAGCAGCAGCAGCAGCGCCTGCATAG 641 CTCCACTCTGACCTGTGAAGGAATGGGGATGAGGCCAGGAGCTAGTGTCTACCACGGCCACACAGGGAGCAGTGTGGGCC 721 CTTAGCCCCCAAGGGGCCTGCTATGCATGTGGCTTTTTTTTTTTTTTTAAACACAGTAAACTAGATTAGTCGTCAGTGTT 801 TTAATTGCCCCTCTTCTCCTCTCCTGCATTCCTCTCCTCTCTTCTTTCCTCTCTGTCCCTTCTCTTTCCCCTCTCAACCA 881 GGAGACCATCATGTCTCTCTGCCTTCCTCCTCTCCCCTCCAGGGGAGTCAGGCTGTCTGTGAAAGCCATGAGCTTCTCTC 961 CCTCTCCCACTCCTCCTCTCCTACTTTCAGATGGATTTATTCCTTTTTTAAACAATGAACATCGGAAATGAGACTGTGGG 1041 GTGTGGTTTCTCTCTCTCTTTTTTTTTTAATTTTCTTTGTTGGGTTTTTGAGCAACCTCATGTCCCCTTCCCAGGGAGCT 1121 TTTTAATTTACCTCTTAGAACTCAAGTGGATGGGAAGTAGAGCACTATGTGTCAGTATGCTTTGTTTTCTGACACGATTA 1201 CACAGCGAGGCTTTAATGCCATTTGGGTAGGTGAGCTTCTGCACTTCTGTTGTGCTGAACTGTATTTTCTTCTCTCATCT 1281 CCTCTTTGTCTTTTTCTCTTTTCCTCTCCTTCCTGCCTTCTTCTGCTGGCCTCCTTTTCTCTTTCTTTACCTTCCTTGGA 1361 TTATCCTTCCAGGTTTTCATAATAAATTTATATTTTGTAAAAGGATTTTGTTGTACCAGGTTTTGCATCCTCACTGAATC 1441 TGACTGGCTTTTATTTTCCTCTCCAAAATCAGGTTTTTGTTCTCAACATCTTTCCCCATCATGTCTAGTCACTGTTTTGG 1521 TTTTGGCACCATCAGTATCAAATGTACAAACGGTTCTTGCTAACCAACACCAGGTATATCTGATGTTCAGATGAGTTCCA 1601 ATAAAAATAATTTTTTTTTTTTTCAAAAGGTGTCTTTTTCTTGAGTGCTGGAGGGCTTCCAAGCAAGTCCAGACAGCTCT 1681 GTGTGGCCCCACACTAGTCTAGCTCTCATCTGGCCAAAGCTGTTATCTCATTTGTGTAATGGGAGTCCTTAAGGTAAATT 1761 TGGGGTCCAAACTTGGAGGGCTTTGGGGGCAAGAAAGTTGGTGTGTGAGTTCTGAGGTTGGAAATGAGTTCAGGTGTCTT 1841 CTTCCAGGGCAGCATGGTCCAGTGAGCACATGTAAGTTTGGGCAGTAGATCCTCTGAGCCTACTTTCTCTTCTACTCAGT 1921 GAGGATGCTGCTTCCTTGGCAGGTGATTGTGATGTGAAGCTTAGTAAGTCATAGACGTGCAGGTGTCTGGAGAGTCCTGA 2001 CATGCAGTTGTGGTTTCGTTTCCTTTTGGAATCTTCAAAGGCAGCGATTTTCATATTGCCTCACACCCTGGCGGGGGCGG 2081 GGGGCTCTGGGACCACTGGGGGACCTGCTAAATCCTCTTCAGTCTGAGCAGTTCAGCCATTGTCAGTTTTAGTATTGTGT 2161 CTCTGTATTTCACTTGCAGAAAGAGCTTTGCTTCTATAAAGGACTTTAAAAAGTACTCCAAAGAGATCTAGTTTTGGAGT 2241 AGAGGGGAGATGTTTTCTCAAACTTAGGGCAGTCCTGAGATGCTCAGGCAGTAGCCCTTTTCTCAGTTCCCTTTGCGGGT 2321 CTTGGTCAGATGATGCCCTCTAGACCCGTGCTGTCCAATATGTAGCCGCTAGCCATGTGCAGCTGTCAGGCCCTTGCAAC 2401 GTGGCTGGTTCGAGCTGTGATACACTGCAAGTGTAAACACAAACCAGACTTCGAAGGCTTAGTATGATAACAAAAGAAAA 2481 GGAGTGTAAAATATGTCAATAACTTTTTTATATATGTGTTGAAATATTTTGGGTATTGGGTTAAATAAAATATATTATTA 2561 AAATTCAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | C8166 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000261712.3 | 3UTR | CCUCCUCUCCCCUCCAGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
57 hsa-miR-4254 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT061595 | BTG2 | BTG anti-proliferation factor 2 | 2 | 4 | ||||||||
MIRT306302 | ABCC5 | ATP binding cassette subfamily C member 5 | 2 | 2 | ||||||||
MIRT353697 | ACTR2 | ARP2 actin related protein 2 homolog | 2 | 2 | ||||||||
MIRT442351 | RAB6B | RAB6B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT448535 | RIMS4 | regulating synaptic membrane exocytosis 4 | 2 | 2 | ||||||||
MIRT449881 | CYP3A5 | cytochrome P450 family 3 subfamily A member 5 | 2 | 2 | ||||||||
MIRT457644 | ZNF69 | zinc finger protein 69 | 2 | 2 | ||||||||
MIRT458620 | TRIM72 | tripartite motif containing 72 | 2 | 2 | ||||||||
MIRT470963 | PKM | pyruvate kinase, muscle | 2 | 2 | ||||||||
MIRT476285 | GMFB | glia maturation factor beta | 2 | 10 | ||||||||
MIRT477615 | EFNA3 | ephrin A3 | 2 | 2 | ||||||||
MIRT482761 | TMEM126B | transmembrane protein 126B | 2 | 2 | ||||||||
MIRT492535 | PSMD11 | proteasome 26S subunit, non-ATPase 11 | 2 | 2 | ||||||||
MIRT502995 | CCDC71L | coiled-coil domain containing 71 like | 2 | 8 | ||||||||
MIRT508467 | HOXB6 | homeobox B6 | 2 | 4 | ||||||||
MIRT520190 | WBP2 | WW domain binding protein 2 | 2 | 2 | ||||||||
MIRT525117 | PRKD2 | protein kinase D2 | 2 | 2 | ||||||||
MIRT525773 | SOD2 | superoxide dismutase 2 | 2 | 2 | ||||||||
MIRT526411 | TFAM | transcription factor A, mitochondrial | 2 | 2 | ||||||||
MIRT528152 | AGTPBP1 | ATP/GTP binding protein 1 | 2 | 2 | ||||||||
MIRT534111 | SOGA3 | SOGA family member 3 | 2 | 2 | ||||||||
MIRT538026 | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | 2 | 2 | ||||||||
MIRT539288 | ANGEL2 | angel homolog 2 | 2 | 2 | ||||||||
MIRT541103 | RAF1 | Raf-1 proto-oncogene, serine/threonine kinase | 2 | 2 | ||||||||
MIRT550999 | SUOX | sulfite oxidase | 2 | 2 | ||||||||
MIRT562165 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT570122 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | 2 | 2 | ||||||||
MIRT571104 | DENND4B | DENN domain containing 4B | 2 | 2 | ||||||||
MIRT574099 | VASN | vasorin | 2 | 2 | ||||||||
MIRT611153 | ZNF486 | zinc finger protein 486 | 2 | 2 | ||||||||
MIRT612252 | STX1B | syntaxin 1B | 2 | 4 | ||||||||
MIRT614808 | RIOK3 | RIO kinase 3 | 2 | 2 | ||||||||
MIRT622153 | SORBS2 | sorbin and SH3 domain containing 2 | 2 | 2 | ||||||||
MIRT624286 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT624875 | ABCC12 | ATP binding cassette subfamily C member 12 | 2 | 2 | ||||||||
MIRT627479 | STRN | striatin | 2 | 2 | ||||||||
MIRT641273 | AMDHD2 | amidohydrolase domain containing 2 | 2 | 2 | ||||||||
MIRT645622 | TSPAN6 | tetraspanin 6 | 2 | 2 | ||||||||
MIRT650226 | SIGLEC9 | sialic acid binding Ig like lectin 9 | 2 | 2 | ||||||||
MIRT657507 | HBEGF | heparin binding EGF like growth factor | 2 | 2 | ||||||||
MIRT660811 | AHCY | adenosylhomocysteinase | 2 | 2 | ||||||||
MIRT667439 | METTL14 | methyltransferase like 14 | 2 | 2 | ||||||||
MIRT693744 | ACACA | acetyl-CoA carboxylase alpha | 2 | 2 | ||||||||
MIRT697852 | UBE2Z | ubiquitin conjugating enzyme E2 Z | 2 | 2 | ||||||||
MIRT698719 | SUMO2 | small ubiquitin-like modifier 2 | 2 | 2 | ||||||||
MIRT699980 | RREB1 | ras responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT700689 | POLR3D | RNA polymerase III subunit D | 2 | 2 | ||||||||
MIRT703267 | GNL3L | G protein nucleolar 3 like | 2 | 2 | ||||||||
MIRT703787 | FAM102B | family with sequence similarity 102 member B | 2 | 2 | ||||||||
MIRT711277 | SDR9C7 | short chain dehydrogenase/reductase family 9C member 7 | 2 | 2 | ||||||||
MIRT711863 | TRAF2 | TNF receptor associated factor 2 | 2 | 2 | ||||||||
MIRT712451 | KHNYN | KH and NYN domain containing | 2 | 2 | ||||||||
MIRT714449 | UBXN2A | UBX domain protein 2A | 2 | 2 | ||||||||
MIRT718846 | SNX20 | sorting nexin 20 | 2 | 2 | ||||||||
MIRT721333 | IFNAR2 | interferon alpha and beta receptor subunit 2 | 2 | 2 | ||||||||
MIRT723315 | PRKCH | protein kinase C eta | 2 | 2 | ||||||||
MIRT736659 | CYP2B6 | cytochrome P450 family 2 subfamily B member 6 | 1 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|